Showing results (11-20 of 150) with videos related to

Sort By:
Pageof 15
Blood Cancer Journal|January 3, 2015
Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcomeM M Patnaik, E A Wassie, E Padron, et al.
Cancer Research|January 13, 2001
Identification of a caspase-2 isoform that behaves as an endogenous inhibitor of the caspase cascadeN Droin, M Beauchemin, E Solary, et al.
Experimental Cell Research|August 1, 1993
Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitorsR Bertrand, E Solary, J Jenkins, et al.
Cell Biology and Toxicology|April 29, 1998
Proteases, proteolysis, and apoptosisE Solary, B Eymin, N Droin, et al.
Experimental Cell Research|December 1, 1992
Radiolabeling of DNA can induce its fragmentation in HL-60 human promyelocytic leukemic cellsE Solary, R Bertrand, J Jenkins, et al.
Cancer Research|February 15, 1997
Increased gadd153 messenger RNA level is associated with apoptosis in human leukemic cells treated with etoposideB Eymin, L Dubrez, M Allouche, et al.
The EMBO Journal|October 15, 1996
Pivotal role of a DEVD-sensitive step in etoposide-induced and Fas-mediated apoptotic pathwaysL Dubrez, I Savoy, A Hamman, et al.
Blood|March 1, 1993
Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitorsE Solary, R Bertrand, K W Kohn, et al.
Biochemical and Biophysical Research Communications|March 19, 1999
STAT-1-independent upregulation of FADD and procaspase-3 and -8 in cancer cells treated with cytotoxic drugsO Micheau, A Hammann, E Solary, et al.
Leukemia|June 1, 1995
The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitorsL Dubrez, F Goldwasser, P Genne, et al.
Pageof 15